Bladder cancer Board decisions

The Board has decided to remand the case due to errors in assessing the severity of the appellant's bladder cancer and residuals thereof, specifically regarding the impact of medications on his symptoms. The AOJ is instructed to obtain a retrospective medical opinion clarifying these issues.

The Veteran's initial compensable evaluation for service-connected hypothyroidism was denied.,The Veteran's bladder cancer, in remission, is being remanded for further evaluation.

The Veteran is granted TDIU for his service-connected PTSD from March 15, 2018, to March 17, 2021. SMC at the housebound rate is also granted as of September 1, 2023.

The Board has found that the remand directives were not substantially complied with in a previous VA medical opinion, and thus another remand is necessary to address the Veteran's urinary frequency and hypertension related to his service-connected bladder cancer.

The Veteran's lung and prostate cancers are related to his exposures to toxic herbicides. Service connection for both disorders is granted on a presumptive basis under the PACT Act. The claims for kidney cancer, bladder cancer, and peripheral neuropathy are remanded due to lack of VA medical opinions.

The Board has granted service connection for prostate cancer and coronary arteriosclerosis, but has remanded the cases of urinary bladder cancer and hypothyroidism due to lack of evidence.

The Veteran's bladder cancer is related to his military service and granted. The issues of heart disability, diabetes mellitus, neck disability, and hypertension are remanded due to duty-to-assist errors.

The Board has granted service connection for prostate cancer and coronary arteriosclerosis, but has remanded the cases of urinary bladder cancer and hypothyroidism due to lack of evidence.

The Veteran's claim for service connection for bladder cancer was granted. The heart disability claim is remanded for readjudication on the merits. Service connection for thyroid disability is granted based on herbicide agent exposure.

The Board has granted service connection for bladder cancer, finding that the Veteran was exposed to herbicide agents in Thailand during his military service. The cause of death claim is dismissed as it has already been granted.

The Board has ordered a remand due to the need for an adequate medical opinion regarding the etiology of the Veteran's bladder cancer, including consideration of her service exposure and any secondary conditions.

The Board has remanded the Veteran's claim due to insufficient evidence regarding his exposure claims and a need for further development in several areas, including radiation exposure and environmental exposures at specific locations.

The Veteran's appeal for service connection of gallbladder cancer has been dismissed due to their death.

The Veteran's diabetes mellitus, type II is granted as presumptively related to his exposure to herbicide agents during service in Vietnam. The initial compensable rating for bladder cancer is remanded due to inadequate examination.

The Veteran's left renal pelvic carcinoma with bladder cancer remains active and malignant, meeting the criteria for a 100% evaluation effective July 1, 2020.

The Board has remanded the claim of service connection for bladder cancer due to in-service asbestos exposure, as it requires additional development and an opinion from a VA examiner.

The Veteran's bladder cancer is presumed to be due to exposure to herbicide agents during service, specifically while maintaining C-123 aircraft. The Board granted service connection for the condition based on this presumption.

Your bladder cancer has been granted service connection, so the appeal is dismissed as moot.

The Board has remanded the claims for rectal cancer and liver cancer due to exposure at Camp Lejeune, but denied an earlier effective date for bladder cancer.

The Veteran's bladder cancer residuals are rated at 40 percent, effective December 1, 2021. The appeal for an earlier effective date for DIC benefits is denied.